Product Images Difluprednate Ophthalmic Emulsion

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Difluprednate Ophthalmic Emulsion NDC 43598-588 by Dr. Reddy's Laboratories Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

bottle label - bottle label

bottle label - bottle label

This is a description of a pharmaceutical product named "Difluprednate Ophthalmic Emulsion 0.05%". It is manufactured and distributed by Dr. Reddy's Laboratories Inc. The product comes in a 5mL container and the recommended storage temperature is between 15°C and 25°C. The product should not be frozen and should be protected from light. There are some codes and numbers on the package, including the NDC code 43598-588-11, an expiration date, and a lot number. The recommended dosage can be found in the package insert.*

carton label - carton label

carton label - carton label

This is a description of a medication called Difluprednate Ophthalmic Emulsion used for topical ophthalmic use only. This medication is distributed by Dr. Reddy's Laboratories Inc. and is made in India. The medication comes in a 5mL bottle and the usual dosage can be found in the package insert. It is important to store this medication between 15°C to 25°C and to protect it from light. The medication contains active ingredient difluprednate 0.05% along with sorbic acid 0.1% as a preservative and other inactive ingredients such as boric acid, castor oil, glycerin, polysorbate 80, water for injection, sodium acetate anhydrous, edetate disodium dihydrate, sodium hydroxide to adjust the pH.*

figure 1 - figure1

figure 1 - figure1

This is a description of the percentage of subjects with anterior chamber cells clearing after taking Difluprednate ophthalmic emulsion 0.05% four times a day for 15 days. The results show that 100% of the subjects had their cell count reduced to zero. The study also compares the effect of the drug with a placebo, showing that the drug had a statistically significant effect (P<0.05).*

figure 2 - figure2

figure 2 - figure2

The data shows the percentage of subjects who were pain-free after receiving Difluprednate ophthalmic emulsion 0.05% QID compared to the placebo group on Day 3, Day 6, Day 15. The treatment group showed a statistically significant improvement in pain relief compared to the placebo group.*

logo - logo

logo - logo

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.